Syncona

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.

Syncona favicon
Founded 2012 · Venture Capital
London (United Kingdom), St. Peter Port ([object Object])
Investment Stages
Series A
Series B
Series C
Markets
Oncology
Ophthalmology
Cell therapy
Gene therapy
Renal
Cardioprotection
Immunology
Rare diseases
Portfolio Companies

Autolus Therapeutics, Beacon Therapeutics, iOnctura, Spur Therapeutics, Quell Therapeutics, Anaveon, Resolution Therapeutics, Purespring Therapeutics, Forcefield Therapeutics, OMass Therapeutics, Mosaic Therapeutics, Kesmalea Therapeutics, Yellowstone Biosciences, Slingshot Therapeutics, Gyroscope Therapeutics, Blue Earth, Nightstar, Neogene Therapeutics, 14MG, Azeria Therapeutics, Clade Therapeutics

Links
Website Team Page Portfolio LinkedIn X Crunchbase PitchBook
Related VC firms in United Kingdom
Ten Eleven Ventures favicon
Ten Eleven Ventures
Cybersecurity
13books Capital favicon
13books Capital
Fintech
1818 Venture Capital favicon
1818 Venture Capital
Fintech, Financial Inclusion, Future of Work, Health & Wellness, Net Zero & Green Mobility, Future of Learning & Development
Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup